Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer
Authors
Keywords
docetaxel liposome, gene delivery, lung cancer, PFKFB, shRNA
Journal
PHARMACEUTICAL RESEARCH
Volume 34, Issue 11, Pages 2371-2384
Publisher
Springer Nature
Online
2017-09-06
DOI
10.1007/s11095-017-2244-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment
- (2017) Cedar H.A. Boakye et al. JOURNAL OF CONTROLLED RELEASE
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ultra-flexible nanocarriers for enhanced topical delivery of a highly lipophilic antioxidative molecule for skin cancer chemoprevention
- (2016) Cedar H.A. Boakye et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer
- (2016) Ravi Doddapaneni et al. EXPERIMENTAL CELL RESEARCH
- Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer
- (2016) Ketan Patel et al. MOLECULAR PHARMACEUTICS
- Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer
- (2016) Ketan Patel et al. Nanomedicine
- Structure-Based Design of Potent and Selective Inhibitors of the Metabolic Kinase PFKFB3
- (2015) Scott Boyd et al. JOURNAL OF MEDICINAL CHEMISTRY
- Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast Cancer
- (2015) Ketan Patel et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
- (2015) Nirmala Chandralega Kampan et al. Biomed Research International
- Abstract 962: Identification of a PFKFB3 inhibitor suitable for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
- (2015) Julie O'Neal et al. CANCER RESEARCH
- Modeling cancer glycolysis under hypoglycemia, and the role played by the differential expression of glycolytic isoforms
- (2014) Alvaro Marín-Hernández et al. FEBS Journal
- PEG — A versatile conjugating ligand for drugs and drug delivery systems
- (2014) Atul Kolate et al. JOURNAL OF CONTROLLED RELEASE
- 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27
- (2014) A Yalcin et al. Cell Death & Disease
- p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents
- (2013) Xinbing Sui et al. CANCER LETTERS
- Tumor glycolysis as a target for cancer therapy: progress and prospects
- (2013) Shanmugasundaram Ganapathy-Kanniappan et al. Molecular Cancer
- Targeting 6-Phosphofructo-2-Kinase (PFKFB3) as a Therapeutic Strategy against Cancer
- (2013) B. F. Clem et al. MOLECULAR CANCER THERAPEUTICS
- Ascorbic Acid and a Cytostatic Inhibitor of Glycolysis Synergistically Induce Apoptosis in Non-Small Cell Lung Cancer Cells
- (2013) Saleha B. Vuyyuri et al. PLoS One
- Caspase Functions in Cell Death and Disease
- (2013) D. R. McIlwain et al. Cold Spring Harbor Perspectives in Biology
- Prolonged mitotic arrest triggers partial activation of apoptosis, resulting in DNA damage and p53 induction
- (2011) James D. Orth et al. MOLECULAR BIOLOGY OF THE CELL
- Mechanisms and functions of p38 MAPK signalling
- (2010) Ana Cuadrado et al. BIOCHEMICAL JOURNAL
- RNA-Based Gene Therapy for HIV with Lentiviral Vector-Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma
- (2010) D. L. DiGiusto et al. Science Translational Medicine
- siRNA vs. shRNA: Similarities and differences
- (2009) Donald D. Rao et al. ADVANCED DRUG DELIVERY REVIEWS
- RNA Interference: From Basic Research to Therapeutic Applications
- (2009) Jens Kurreck ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- High transfection efficiency and low toxicity cationic lipids with aminoglycerol–diamine conjugate
- (2008) Boon-ek Yingyongnarongkul et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Glycolytic enzyme inhibitors in cancer treatment
- (2008) Roberto Scatena et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth
- (2008) B. Clem et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started